Neoadjuvant chemotherapy plus camrelizumab for locally advanced cervical cancer (NACI study): a multicentre, single-arm, phase 2 trial by Li, Kezhen, Prof, Chen, Jing, MD, Hu, Yingjie, MD, Wang, Yan-Zhou, Prof, Shen, Yuanming, Prof, Chen, Gang, Prof, Peng, Wenju, MD, Fang, Zixuan, MD, Xia, Bairong, Prof, Chen, Xiaojun, Prof, Song, Kun, Prof, Wang, Yingmei, Prof, Zou, Dongling, Prof, Wang, Yan-Chun, PhD, Han, Yingyan, PhD, Feng, Xue, MD, Yuan, Jing, PhD, Guo, Shuaiqingying, BM, Meng, Xiaolin, BM, Feng, Chenzhao, MD, Chen, Yin, Prof, Yang, Jie, Prof, Fan, Junpeng, PhD, Wang, Jianliu, Prof, Ai, Jihui, Prof, Ma, Ding, Prof, Sun, Chaoyang, Prof

Get full text